review Open AccessTop 1% cited
Male breast cancer: a disease distinct from female breast cancer
Breast Cancer Research and Treatment · 2018 · Vol. 173(1) · pp. 37–48
Ayca Gucalp✉(Memorial Sloan Kettering Cancer Center)Tiffany A. Traina(Memorial Sloan Kettering Cancer Center)Joel R. Eisner(Innocrin Pharmaceuticals (United States))Joel S. Parker(University of North Carolina at Chapel Hill)Sara R. Selitsky(University of North Carolina at Chapel Hill)Ben Ho Park(Sidney Kimmel Comprehensive Cancer Center)Anthony Elias(University of Colorado Anschutz Medical Campus)Edwina Baskin-Bey(Innocrin Pharmaceuticals (United States))Fátima Cardoso(Champalimaud Foundation)
Male Breast Health StudiesBRCA gene mutations in cancerCancer and Skin LesionsMale breast cancerBreast cancerMedicineOncologyDiseaseCancerEpidemiologyInternal medicineClinical trial
MeSH terms
Antineoplastic AgentsBreast NeoplasmsClinical Trials as TopicFemaleHumansMaleGene Expression Regulation, NeoplasticSEER ProgramBreast Neoplasms, MaleEpigenesis, Genetic
Funding
- Breast Cancer Research Foundation
- Translational Breast Cancer Research Consortium
Citations
372
FWCI
20.45
field-weighted impact
References
89
Percentile
100%
vs. same field & year
Citations per year
Cited by
A critical review on: Comprehending breast cancer in men with reference to female
National Journal of Pharmaceutical Sciences · 2024 · 1 citations
References
Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families
The American Journal of Human Genetics · 1998 · 3,035 citations
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Journal of Clinical Oncology · 2009 · 4,815 citations
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
Annals of Oncology · 2016 · 2,058 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.